News

After being diagnosed with prostate cancer, men who eat a diet high in vegetable fats may be less likely to have their disease spread.

Scientists have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment.

Pearl Therapeutics is focused on the development of inhaled small-molecule therapeutics for respiratory disease.

First international company using cell culture technology to produce biopharmaceuticals in China.

Healthy cells live in a delicate balance between growth-promoting genes (oncogenes) and those who restrain it (anti-oncogenes or tumor suppressor genes).

New partnership gives researchers and scientists in the University, Government and Commercial Laboratory Sector improved access to Promega’s world class product range.

Companies have achieved a breakthrough in the development of two Staphylococcus aureus-based phage products for Phase I clinical trials.

The expression of specific genes is partially dictated by the way the DNA is packed into chromatin, a tightly packed combination of DNA and proteins known as histones.

Company to supply a range of authentic Pfizer compounds to researchers.

The University of Bristol’s efforts to be environmentally friendly and ethical are first class, according to a new league table.